Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression

[1]  K. Hashimoto.  Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[2]  K. Hashimoto,et al.  Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist , 2015, European Neuropsychopharmacology.

[3]  K. Hashimoto,et al.  Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression , 2015, Psychopharmacology.

[4]  L. Qiu,et al.  Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects , 2015, European Psychiatry.

[5]  Rong Lv,et al.  Paeoniflorin improves menopause depression in ovariectomized rats under chronic unpredictable mild stress. , 2015, International journal of clinical and experimental medicine.

[6]  L. Qiu,et al.  Loss of Phenotype of Parvalbumin Interneurons in Rat Prefrontal Cortex Is Involved in Antidepressant- and Propsychotic-Like Behaviors Following Acute and Repeated Ketamine Administration , 2015, Molecular Neurobiology.

[7]  K. Hashimoto,et al.  Regional Differences in Brain-Derived Neurotrophic Factor Levels and Dendritic Spine Density Confer Resilience to Inescapable Stress , 2015, The international journal of neuropsychopharmacology.

[8]  K. Hashimoto,et al.  Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders. , 2015, Current molecular medicine.

[9]  C. Zarate,et al.  Antidepressant actions of ketamine: from molecular mechanisms to clinical practice , 2015, Current Opinion in Neurobiology.

[10]  Yuko Fujita,et al.  Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation , 2015, The international journal of neuropsychopharmacology.

[11]  B. Cohen,et al.  Blockade of the GLT-1 Transporter in the Central Nucleus of the Amygdala Induces both Anxiety and Depressive-Like Symptoms , 2015, Neuropsychopharmacology.

[12]  M. Walter,et al.  Multistage drug effects of ketamine in the treatment of major depression , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[13]  K. Hashimoto.  Targeting of NMDA receptors in new treatments for schizophrenia , 2014, Expert opinion on therapeutic targets.

[14]  S. Maier,et al.  Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis , 2014, Molecular Psychiatry.

[15]  R. Duman.  Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections , 2014, Dialogues in clinical neuroscience.

[16]  N. Danbolt,et al.  GABA and Glutamate Transporters in Brain , 2013, Front. Endocrinol..

[17]  R. Duman,et al.  Environmental and pharmacological modulations of cellular plasticity: Role in the pathophysiology and treatment of depression , 2013, Neurobiology of Disease.

[18]  K. Hashimoto.  Therapeutic implications for NMDA receptors in mood disorders , 2013, Expert review of neurotherapeutics.

[19]  J. Krystal,et al.  Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond , 2013, Biological Psychiatry.

[20]  K. Hashimoto,et al.  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders , 2013, European Archives of Psychiatry and Clinical Neuroscience.

[21]  E. Palazidou.  The neurobiology of depression. , 2012, British medical bulletin.

[22]  R. Duman,et al.  Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents , 2012, Trends in Neurosciences.

[23]  Zhen Yan,et al.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission , 2011, Nature Reviews Neuroscience.

[24]  Nanxin Li,et al.  Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine. , 2011, The international journal of neuropsychopharmacology.

[25]  E. Kavalali,et al.  NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.

[26]  Nanxin Li,et al.  Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure , 2011, Biological Psychiatry.

[27]  Jun Ma,et al.  Fates-shifted, a novel F-box protein that targets Bicoid for degradation, regulates developmental fate determination in Drosophila embryos , 2010, Nature Cell Biology.

[28]  Kenji Hashimoto,et al.  Brain‐derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions , 2010, Psychiatry and clinical neurosciences.

[29]  Kazuyuki Nakagome,et al.  Hippocampal astrocytes are necessary for antidepressant treatment of learned helplessness rats , 2010, Hippocampus.

[30]  H. Manji,et al.  Cellular mechanisms underlying affective resiliency: The role of glucocorticoid receptor- and mitochondrially-mediated plasticity , 2009, Brain Research.

[31]  J. G. Bjaalie,et al.  The concentrations and distributions of three C-terminal variants of the GLT1 (EAAT2; slc1a2) glutamate transporter protein in rat brain tissue suggest differential regulation , 2009, Neuroscience.

[32]  Eric J. Nestler,et al.  The molecular neurobiology of depression , 2008, Nature.

[33]  B. McEwen,et al.  BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments , 2008, Proceedings of the National Academy of Sciences.

[34]  M. Galloway,et al.  Repeated Unpredictable Stress and Antidepressants Differentially Regulate Expression of the Bcl-2 Family of Apoptotic Genes in Rat Cortical, Hippocampal, and Limbic Brain Structures , 2008, Neuropsychopharmacology.

[35]  N. Sousa,et al.  Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: The role of glycogen-synthase-kinase-3β , 2008, Neuroscience.

[36]  Guang Chen,et al.  Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors , 2008, Biological Psychiatry.

[37]  G. Réus,et al.  Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  M. Banasr,et al.  Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. , 2007, CNS & neurological disorders drug targets.

[39]  JaneR . Taylor,et al.  Chronic Unpredictable Stress Decreases Cell Proliferation in the Cerebral Cortex of the Adult Rat , 2007, Biological Psychiatry.

[40]  G. Rajkowska,et al.  Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.

[41]  E. Castrén,et al.  Role of neurotrophic factors in depression. , 2007, Current opinion in pharmacology.

[42]  Y. Mineur,et al.  Antidepressant-Like Effects of Ceftriaxone in Male C57BL/6J Mice , 2007, Biological Psychiatry.

[43]  Eberhard Fuchs,et al.  Stress, depression and hippocampal apoptosis. , 2006, CNS & neurological disorders drug targets.

[44]  B. Czéh,et al.  Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment , 2006, Neuropsychopharmacology.

[45]  G. Carmignoto,et al.  Astrocyte control of synaptic transmission and neurovascular coupling. , 2006, Physiological reviews.

[46]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[47]  E. Nestler,et al.  The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.

[48]  K. Shimamoto,et al.  Sulfhydryl modification of cysteine mutants of a neuronal glutamate transporter reveals an inverse relationship between sodium dependent conformational changes and the glutamate-gated anion conductance , 2005, Neuropharmacology.

[49]  P. Fisher,et al.  β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.

[50]  Robert M. Sapolsky,et al.  Stress and Plasticity in the Limbic System , 2003, Neurochemical Research.

[51]  K. Denicoff,et al.  Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders , 2003, Annals of the New York Academy of Sciences.

[52]  Olga V. Demler,et al.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.

[53]  D. Ginty,et al.  Function and Regulation of CREB Family Transcription Factors in the Nervous System , 2002, Neuron.

[54]  F. Holsboer,et al.  Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus , 2001, The European journal of neuroscience.

[55]  N. Danbolt.  Glutamate uptake , 2001, Progress in Neurobiology.

[56]  M. Murer,et al.  Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.

[57]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[58]  C. Venero,et al.  Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats , 1999, The European journal of neuroscience.

[59]  Steven Finkbeiner,et al.  Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism , 1998, Neuron.

[60]  B. Yamamoto,et al.  Rapid Communication: Adrenalectomy Attenuates Stress‐Induced Elevations in Extracellular Glutamate Concentrations in the Hippocampus , 1993, Journal of neurochemistry.

[61]  Jian-xin Chen 陈建新,et al.  Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress , 2014, Journal of Huazhong University of Science and Technology [Medical Sciences].

[62]  Patricia A. Berglund,et al.  The Epidemiology of Major Depressive Disorder , 2009 .

[63]  C. Pittenger,et al.  Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.

[64]  E. Cadenas,et al.  Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain , 2007 .

[65]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[66]  B. Pitt.  Psychopharmacology , 1968, Mental Health.